Association between vitamin D polymorphisms and binding protein and COVID-19 risk and severity in children
Clinical and Experimental Pediatrics · 15.12.2025 · 68 (12) · 998-1006
DOI: 10.3345/cep.2025.00577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pediatrics, erschienen am 15.12.2025. Verfasst von Victoria Giatraki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University Hospital of Heraklion, Medical School University of Crete, Crete, Greece. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Crete.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The effects of genetic background on the biological effects of vitamin D on coronavirus disease 2019 (COVID-19) in children remain unclear.
Purpose
This study aimed to explore the association between vitamin D-related genetic background and 25-hydroxyvitamin D status and COVID-19 occurrence and severity in children. Here we explored key genetic variants within the vitamin D pathway in pediatric COVID-19 patients in relation to circulating vitamin D binding protein (VDBP).
Methods
Sixty children aged 0–14 years with severe acute respiratory syndrome coronavirus 2 infection and 60 matched controls were genotyped for the vitamin D receptor (VDR) gene (FokI, BsmI, TaqI, ApaI), Gc gene of VDBP (rs7041, rs4588), and CYP27B1 promoter (rs10877012) single nucleotide polymorphisms by polymerase chain reaction and restriction fragment length polymorphism assay.
Results
The FokI FF genotype was more frequently identified among COVID-19 patients than controls, among whom the TaqI TT genotype was prevalent (odds ratio [OR], 2.26; 95% confidence interval [CI], 1.08–4.73; P=0.02; and OR, 0.29; 95% CI, 0.13–0.63; P=0.001, respectively). The Gc1F haplotype was significantly more represented in controls versus COVID-19 patients (OR, 0.39; 95% CI, 0.19–0.81; P=0.01). A 2.04-fold increased risk of COVID-19 was observed in the presence of the VDR FokI F allele (OR, 2.04; 95% CI, 1.14–3.64; P=0.01). A multivariate analysis revealed a significant association between the FokI FF genotype and disease severity (OR, 0.20; 95% CI, 0.04–0.83; P=0.02). Serum VDBP levels were similar between groups.
Conclusion
The FF genotype of the VDR FokI polymorphism may be associated with COVID-19 and have a significant clinical impact on disease severity in children.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, University Hospital of Heraklion, Medical School University of Crete, Crete, Greece.
- Laboratory of Child's Health, Division of Mother and Child Health, Medical School University of Crete, Crete, Greece.
- Laboratory of Clinical Chemistry, Department of Laboratory Medicine, Medical School University of Crete, Crete, Greece.
Förderung
- University of Crete
Zitieren
APA
Giatraki, V., Dimitriou, H., Martimianaki, G., Tsatsanis, C., Galanakis, E., & Perdikogianni, C. (2025). Association between vitamin D polymorphisms and binding protein and COVID-19 risk and severity in children. Clinical and Experimental Pediatrics, 68(12), 998-1006. https://doi.org/10.3345/cep.2025.00577
Vancouver
Giatraki V, Dimitriou H, Martimianaki G, Tsatsanis C, Galanakis E, Perdikogianni C. Association between vitamin D polymorphisms and binding protein and COVID-19 risk and severity in children. Clinical and Experimental Pediatrics. 2025;68(12):998-1006. doi:10.3345/cep.2025.00577
BibTeX
@article{Giatraki2025,
author = {Giatraki, Victoria and Dimitriou, Helen and Martimianaki, Georgia and Tsatsanis, Christos and Galanakis, Emmanouil and Perdikogianni, Chrysoula},
title = {Association between vitamin D polymorphisms and binding protein and COVID-19 risk and severity in children},
journal = {Clinical and Experimental Pediatrics},
year = {2025},
volume = {68},
number = {12},
pages = {998--1006},
doi = {10.3345/cep.2025.00577}
}
EUVIMED